SCHEMBL6134397

SCHEMBL6134397

CC(C)n1nc(-c2sc(N)nc2-c2cccc(Cl)c2)ccc1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 2/20 0.53
RORB Q92753 1/20 0.42
ALDH1A1 P00352 4/20 0.38
MAPT P10636 3/20 0.38
MAPK1 P28482 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
POLB P06746 1/20 0.38
KDM5B Q9UGL1 1/20 0.37
CYP1A2 P05177 3/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD17B10 Q99714 3/20 0.35
CYP2C9 P11712 2/20 0.35
ADORA2A P29274 3/20 0.35
ADORA1 P30542 3/20 0.35
BACE1 P56817 1/20 0.35
ADORA2B P29275 1/20 0.34
KDM4E B2RXH2 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133824 0.87 MAPT (0.39) TGFBR1ALDH1A1MAPTMAPK1MEN1
SCHEMBL6134226 0.87 ALDH1A1 (0.51) TGFBR1ALDH1A1MAPTMAPK1MEN1
SCHEMBL6134607 0.86 POLB (0.39) TGFBR1RORBALDH1A1KMT2APOLB
Bromide SCHEMBL6133333 0.85 ALDH1A1 (0.50) TGFBR1ALDH1A1MAPTMAPK1MEN1
SCHEMBL6134087 0.82 POLB (0.40) TGFBR1ALDH1A1POLBHSD17B10KDM4E
SCHEMBL6134033 0.80 TGFBR1 (0.48) TGFBR1ALDH1A1MAPTMAPK1LMNA
SCHEMBL6133413 0.80 PDE4A (0.46) ALDH1A1MAPTLMNAPOLBKDM4E
SCHEMBL6133317 0.79 MAPT (0.46) ALDH1A1MAPTMAPK1POLBKDM4E
SCHEMBL6134599 0.78 ADORA1 (0.53) LMNAPOLBKDM5BCYP1A2HSD17B10
SCHEMBL6133426 0.76 TGFBR1 (0.45) TGFBR1ALDH1A1MAPTKDM5BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed
EP-1441732-A2 THIAZOLE DERIVATIVE AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-04 EP disclosed
WO-2003039451-A2 THIAZOLE PYRIDAZINONES AS ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR TGFBR1 966/4885RORB 188/4885ALDH1A1 630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.